Gyre Therapeutics (GYRE) Share-based Compensation (2010 - 2026)
Gyre Therapeutics' Share-based Compensation came in at $2.08 million for Q2 2026, up 44.5% from $1.44 million a year earlier but down 19.7% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gyre Therapeutics reported Share-based Compensation of $9.87 million, up 259.4% year-over-year; for FY2025, it came in at $7.16 million, up 761.3% from FY2024.
- Share-based Compensation carries a five-year compound annual growth rate of 14.6% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $831,000 in FY2024 (-88.6%), $7.28 million in FY2023 (-45.5%), $13.37 million in FY2022 (+292.5%) and $3.41 million in FY2021 (-6.1%).
- The five-year range for quarterly Share-based Compensation is $11,000 (Q1 2024) to $12.28 million (Q4 2022).
- Year-over-year, Share-based Compensation has increased for four consecutive quarters, with growth averaging 229.2% over the last six quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q4 2025 (growth of 710.8%), and the weakest in Q1 2024 (a decline of 94.8%).
- Business Quant data shows GYRE's Share-based Compensation at $2.58 million (Q1 2026), $4.6 million (Q4 2025) and $617,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | 2.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.08 Mn |
| Mar 31, 2026 | 2.58 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Sep 30, 2025 | 617,000.00 |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 507,000.00 |
| Dec 31, 2024 | 567,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 6.88 Mn |
| Sep 30, 2023 | 98,000.00 |
| Jun 30, 2023 | 89,000.00 |
| Mar 31, 2023 | 210,000.00 |
| Dec 31, 2022 | 12.28 Mn |
| Sep 30, 2022 | 224,000.00 |
| Jun 30, 2022 | 346,000.00 |
| Mar 31, 2022 | 515,000.00 |
| Dec 31, 2021 | 683,000.00 |
| Sep 30, 2021 | 713,000.00 |
API Access
Gyre Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();